Literature DB >> 17873139

MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy?

George Sgouros1, Susan J Knox, Michael C Joiner, William F Morgan, Amin I Kassis.   

Abstract

Bystander and low-dose-rate effects influence the dose-response relationship in a manner not predicted by current dosimetric methodologies. Radiation-induced bystander effects refer to biologic responses in cells that are not traversed by an ionizing radiation track and, thus, not subject to direct energy deposition; that is, the responses occur in nonirradiated cells. Low-dose-rate hypersensitivity effects have been documented as a reduction in the survival of cells irradiated at dose rates of 0.1-1.0 Gy/h, with total doses ranging from 1.5 to 5 Gy. For humans undergoing external radiotherapy, evidence of bystander events has been observed in the form of abscopal effects, wherein irradiation of one portion of the anatomy affects a portion outside the radiation field, whereas low-dose-rate hypersensitivity has not been described. In this report, the historical literature is briefly reviewed, key experiments are summarized, and current understanding of the factors thought to be involved in the bystander and low-dose-rate effects is conveyed. The mechanisms associated with these events are still being investigated, and questions remain on their impact in radionuclide therapy. Although current findings do not yet sufficiently justify changing traditional dose estimates used to predict the outcomes of radionuclide therapy, it is important to appreciate the potential importance of these effects and to begin revising methods to reflect the emerging empiric and mechanistic knowledge.

Entities:  

Mesh:

Year:  2007        PMID: 17873139     DOI: 10.2967/jnumed.105.028183

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  19 in total

Review 1.  Clinical radioimmunotherapy--the role of radiobiology.

Authors:  Jean-Pierre Pouget; Isabelle Navarro-Teulon; Manuel Bardiès; Nicolas Chouin; Guillaume Cartron; André Pèlegrin; David Azria
Journal:  Nat Rev Clin Oncol       Date:  2011-11-08       Impact factor: 66.675

2.  Abscopal effect of low-LET γ-radiation mediated through Rel protein signal transduction in a mouse model of nontargeted radiation response.

Authors:  S Aravindan; M Natarajan; S K Ramraj; V Pandian; F H Khan; T S Herman; N Aravindan
Journal:  Cancer Gene Ther       Date:  2013-12-20       Impact factor: 5.987

3.  Bystander effect in tumor cells produced by Iodine-125 labeled human lymphocytes.

Authors:  Omar Mamlouk; Pichumani Balagurumoorthy; Ketai Wang; S James Adelstein; Amin I Kassis
Journal:  Int J Radiat Biol       Date:  2012-07-09       Impact factor: 2.694

Review 4.  Therapeutic radionuclides: biophysical and radiobiologic principles.

Authors:  Amin I Kassis
Journal:  Semin Nucl Med       Date:  2008-09       Impact factor: 4.446

5.  ¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.

Authors:  Pierre-Yves Salaun; Loïc Campion; Catherine Ansquer; Eric Frampas; Cédric Mathieu; Philippe Robin; Claire Bournaud; Jean-Philippe Vuillez; David Taieb; Caroline Rousseau; Delphine Drui; Eric Mirallié; Françoise Borson-Chazot; David M Goldenberg; Jean-François Chatal; Jacques Barbet; Françoise Kraeber-Bodéré
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-08       Impact factor: 9.236

6.  CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy.

Authors:  Tao Zhang; Mingjian Lu; Sheng Peng; Weidong Zhang; Guang Yang; Zhenyin Liu; Sristi Singh; Yadi Yang; Fujun Zhang; Fei Gao
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-11       Impact factor: 4.553

7.  Induction and repair of DNA double-strand breaks in blood lymphocytes of patients undergoing ¹⁸F-FDG PET/CT examinations.

Authors:  Matthias S May; Michael Brand; Wolfgang Wuest; Katharina Anders; Torsten Kuwert; Olaf Prante; Daniela Schmidt; Simone Maschauer; Richard C Semelka; Michael Uder; Michael A Kuefner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-02       Impact factor: 9.236

8.  Are epigenetic mechanisms involved in radiation-induced bystander effects?

Authors:  Carmel Mothersill; Colin Seymour
Journal:  Front Genet       Date:  2012-05-17       Impact factor: 4.599

9.  Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effects.

Authors:  M D Gow; C B Seymour; M Boyd; R J Mairs; W V Prestiwch; C E Mothersill
Journal:  Dose Response       Date:  2013-05-30       Impact factor: 2.658

Review 10.  Radionuclide carriers for targeting of cancer.

Authors:  Stavroula Sofou
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.